APP and neuroblastoma: MiR-298 significantly reduced (~ 30%) APP and BACE1 mRNA levels in astrocytes (U373) (Fig. 2a,b) but not in differentiated neuroblastoma cells (SK-N-SH) (Fig. 2c,d).